2,718.18
0.00 PLN
−1.11 M PLN
13.23 M PLN
About Read-Gene SA
Sector
Industry
CEO
Jan Lubinski
Website
Headquarters
Dobra
Founded
2005
ISIN
PLRADGN00014
FIGI
BBG000KYH0P6
Read-Gene SA engages in the medical research and testing. It develops cancer prevention treatment based on genetic tests. The company was founded on September 27, 2005 and is headquartered in Dobra, Poland.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RDG is 5.74 PLN — it has decreased by −4.01% in the past 24 hours. Watch Read-Gene SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEWCONNECT exchange Read-Gene SA stocks are traded under the ticker RDG.
RDG stock has fallen by −8.01% compared to the previous week, the last month showed zero change in price, over the last year Read-Gene SA has showed a 0.70% increase.
RDG stock is 4.18% volatile and has beta coefficient of −0.03. Track Read-Gene SA stock price on the chart and check out the list of the most volatile stocks — is Read-Gene SA there?
Today Read-Gene SA has the market capitalization of 67.67 M, it has increased by 8.53% over the last week.
Yes, you can track Read-Gene SA financials in yearly and quarterly reports right on TradingView.
RDG net income for the last quarter is 514.46 K PLN, while the quarter before that showed −297.81 K PLN of net income which accounts for 272.75% change. Track more Read-Gene SA financial stats to get the full picture.
No, RDG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 13, 2025, the company has 24 employees. See our rating of the largest employees — is Read-Gene SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Read-Gene SA EBITDA is 528.83 K PLN, and current EBITDA margin is 0.14%. See more stats in Read-Gene SA financial statements.
Like other stocks, RDG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Read-Gene SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Read-Gene SA technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Read-Gene SA stock shows the buy signal. See more of Read-Gene SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.